2025-07-23 - Analysis Report
Okay, here's the analysis of Air Products and Chemicals Inc. (APD), presented as requested, in English, with a focus on key data points and concise analysis.

**Air Products and Chemicals Inc. (APD) Analysis**

**Company Overview:** Air Products and Chemicals Inc. is an industrial gases company that provides gases and related equipment to various industries.

**1. Performance vs. S&P 500 (VOO)**

*   **APD Cumulative Return:** 34.22%
*   **VOO (S&P 500) Cumulative Return:** 97.07%
*   **Absolute Performance Difference:** -62.86% (APD significantly underperformed VOO)
*   **Relative Performance Divergence:** 2.8 (Indicates APD's relative performance is near its historical lows compared to VOO)

    **Analysis:** APD has significantly lagged the S&P 500 over the analyzed period. The relative divergence score suggests this underperformance is near the lowest end of its historical range compared to the index.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
|------------|-------|-------|--------|------|--------|
| 2015-2017  | 24.0% | 54.4% | -5.0%  | 0.0  | 36.5   |
| 2016-2018  | 20.0% | 60.4% | 2.0%   | 0.2  | 35.6   |
| 2017-2019  | 48.0% | 60.4% | 18.0%  | 0.9  | 52.3   |
| 2018-2020  | 33.0% | 60.4% | 14.0%  | 0.4  | 60.8   |
| 2019-2021  | 59.0% | 59.5% | 11.0%  | 0.3  | 67.7   |
| 2020-2022  | 22.0% | 71.4% | 20.0%  | 0.3  | 68.6   |
| 2021-2023  | -18.0% | 71.4% | -36.0% | 0.8  | 60.9   |
| 2022-2024  | -25.0% | 71.4% | -51.0% | 0.8  | 64.5   |
| 2023-2025  | -48.0% | 71.5% | -97.0% | 1.2  | 66.3   |

**Analysis:**

*   **CAGR:**  CAGR은 2021-2023부터 계속 감소하고 있습니다.
*   **MDD:** Maximum Drawdown, MDD는 변동성이 증가하고 있음을 시사합니다.
*   **Alpha:** Alpha는 S&P 500 대비 초과 수익률을 나타내는데, 최근에는 마이너스 값을 보입니다.
*   **Beta:** Beta는 시장 변동성에 대한 민감도를 나타내는데, 1.2로 시장보다 약간 더 민감합니다.

**2. Recent Stock Price Movement**

*   **Current Price:** $298.13
*   **Previous Close:** $293.72
*   **Change:** 1.5% (Positive jump)
*   **5-Day Moving Average:** $293.95
*   **20-Day Moving Average:** $289.37
*   **60-Day Moving Average:** $279.64

**Analysis:** The stock price is currently above its 5, 20, and 60-day moving averages, suggesting a short-term upward trend. The significant positive change from the previous close indicates a recent bullish movement.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3359 (Low Risk)
*   **RSI:** 67.27 (Approaching overbought territory)
*   **PPO:** 0.1153 (Positive momentum)
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence:** 0.1 (Positive, indicating short-term upward momentum)
*   **Expected Return:** -432.8% (Significantly negative, indicating potential long-term underperformance compared to the S&P 500)

**Analysis:** The RSI approaching overbought territory could signal a potential pullback. The Market Risk Indicator (MRI) suggests low market risk. The very negative expected return suggests caution for long-term investment relative to the broader market.

**4. Recent News & Significant Events:**

*   **[2025-07-19]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-22]:** Analysts are discussing recent performance and outlook.
*   **[2025-07-23]:** Stock has shown notable volatility.
*   **[2025-07-20]:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news points to volatility and ongoing analysis of APD's performance and outlook. Investors should carefully monitor these developments.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-05-01 | -7.77 | 2.92 B$     |
| 2025-02-06 | 2.77  | 2.93 B$     |
| 2024-08-01 | 3.13  | 2.99 B$     |
| 2024-04-30 | 2.57  | 2.93 B$     |
| 2025-05-01 | 2.57  | 2.93 B$     |

**Analysis:**
* EPS: 최근 EPS가 -7.77로 급감했습니다.
* 매출: 매출은 2.92B$ ~ 2.99B$ 사이에서 비교적 안정적입니다.
* EPS가 급감한 것은 우려스러운 신호입니다.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $2.92B   | 29.57%        |
| 2024-12-31   | $2.93B   | 31.21%        |
| 2024-09-30   | $3.19B   | 33.98%        |
| 2024-06-30   | $2.99B   | 32.82%        |
| 2024-03-31   | $2.93B   | 32.04%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-03-31   | $14.70B    | -11.77%   |
| 2024-12-31   | $16.69B    | 3.70%     |
| 2024-09-30   | $17.04B    | 11.45%    |
| 2024-06-30   | $15.10B    | 4.61%     |
| 2024-03-31   | $14.91B    | 3.84%     |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable but experienced decrease.
*   **Profit Margin:** Profit margins have decreased.
*   **Equity:** Equity has decreased.
*   **ROE:** ROE (Return on Equity) has dropped sharply and is now negative, indicating a significant decline in profitability relative to equity.

**7. Overall Analysis:**

*   **Underperformance:** APD has significantly underperformed the S&P 500, and its relative performance is near historical lows.
*   **Recent Positve price change:** The significant positive change from the previous close indicates a recent bullish movement.
*   **Financial Concerns:** Declining profit margins, a sharp drop in ROE, and a recent negative EPS all raise concerns about the company's financial health.
*   **Negative Outlook:** The very negative expected return signals potential long-term underperformance compared to the broader market.
*   **Mixed Signals:**  While there's short-term upward momentum and low market risk indicated by the MRI, caution is warranted.
*   **Monitor News:** It is crucial to closely monitor news and company announcements for further developments.

**Recommendation:** Given the underperformance, declining profitability metrics, and negative long-term expected return, a cautious approach is advised. Investors should carefully evaluate the risks and opportunities based on their individual investment goals and risk tolerance, closely monitoring news and company releases. A deeper investigation into the reasons for the negative EPS and ROE is warranted.
